- Current report filing (8-K)
07 Janeiro 2013 - 12:06PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
January 4, 2013
AETHLON MEDICAL, INC.
(Exact name of registrant as specified in its
charter)
|
|
|
|
|
Nevada
(State or other jurisdiction
of incorporation)
|
|
000-21846
(Commission File Number)
|
|
13-3632859
(IRS Employer
Identification Number)
|
8910 University Center Lane, Suite 660
San Diego, California
(Address of principal executive offices)
|
92122
(Zip Code)
|
Registrant’s telephone number,
including area code: (858) 459-7800
Not applicable
(Former name or former address, if changed since
last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2 below):
|
|
|
£
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
£
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
£
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
£
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
FORWARD LOOKING STATEMENTS
This Form 8-K and other reports filed by Registrant
from time to time with the Securities and Exchange Commission (collectively the "Filings") contain or may contain forward
looking statements and information that are based upon beliefs of, and information currently available to, Registrant's management
as well as estimates and assumptions made by Registrant's management. When used in the Filings the words "anticipate, "believe",
"estimate", "expect", "future", "intend", "plan" or the negative of these terms
and similar expressions as they relate to Registrant or Registrant's management identify forward looking statements. Such statements
reflect the current view of Registrant with respect to future events and are subject to risks, uncertainties, assumptions and other
factors relating to Registrant's industry, Registrant's operations and results of operations and any businesses that may be acquired
by Registrant. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect,
actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.
Although Registrant believes that the expectations
reflected in the forward looking statements are reasonable, Registrant cannot guarantee future results, levels of activity, performance
or achievements. Except as required by applicable law, including the securities laws of the United States, Registrant does not
intend to update any of the forward-looking statements to conform these statements to actual results.
Item 8.01 Other Events.
On January 4, 2013, the Depository Trust Company
(DTC) informed our counsel that DTC has determined to lift the deposit transaction restriction (DTC Chill) imposed on our common
stock and will resume accepting deposits of our common stock for depository and book-entry transfer services.
The removal of the DTC Chill eliminates the
following risk factor which was disclosed in our most recent Form 10-K:
A DTC “CHILL” ON ELECTRONIC CLEARING OF TRADES IN OUR
COMMON STOCK MAY AFFECT THE LIQUIDITY OF OUR STOCK AND OUR ABILITY TO RAISE CAPITAL.
In September 2011, The Depositary Trust Company (DTC) placed a "chill"
on the electronic clearing of trades in our shares which has led to some brokerage firms to be unwilling to accept certificates
and/or electronic deposits of our stock and also some will not accept trades in our shares altogether. We have sought advice from
third parties on removal of the DTC chill and have initiated dialogue with the DTC in order to seek resolution, but can make no
assurances when and/or if the “chill” we be lifted.
The DTC chill affects the liquidity of our
shares which may make it difficult to purchase or sell shares in the open market. It may also have an adverse effect on our ability
to raise capital since investors may be unable to resell shares into the market. Our inability to raise capital on terms acceptable
to us, if at all, could have a material and adverse effect on our business and operations.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
AETHLON MEDICAL, INC.
|
|
|
|
|
|
|
|
|
|
By:
/s/ James A. Joyce
|
|
|
|
|
James A. Joyce
|
Dated: January 7, 2013
|
|
Chief Executive Officer
|
3
Atlas Copco (PK) (USOTC:ATLRF)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Atlas Copco (PK) (USOTC:ATLRF)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024